NEUROPHET, Inc. is an advanced neuroscience company located in Seoul, South Korea. As a leading provider of neuro-navigation technology, NEUROPHET enables clinicians to treat patients more precisely. We strive to make the world healthier by overcoming limitation of brain diseases. We will continue to innovate ourselves and lead the healthcare’s future. With unique expertise in the neuroscience field, Neurophet strives to improve the life of patients suffering from the neurological disorders by providing dianostic and treatment solutions that are relevant and essential for the healthcare providers. Neurophet produces solutions based on Segengine, the company’s own technology that automatically segments brain magnetic resonance (MR) images into 107 regions within a minute.
Total Funding: $5.1 M
Funding Stage: Series A
Business Stage: Scaling Up
Market: B2B
Company Size: 26 to 50
Founded: 2016
For AI Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI Startup founders or founders at NEUROPHET
NEUROPHET - AI Startup | AI Startup Profile Powered by Appengine AI | Appengine AI - AI Ecosystem of 12,000+ AI Startups
NEUROPHET - Manage Profile
World's Most Promising AI Startups
World's Leading AI Ecosystem of AI Startups, Founders, Investors, and AI Professionals
Get Started